Relative to Tardive Dyskinesia Awareness Week
The resolution emphasizes the importance of awareness around TD and its symptoms, which include involuntary movements that can severely affect individuals' quality of life. By establishing an awareness week, it aims to educate both healthcare providers and the general public about the risks associated with DRBAs, particularly for high-risk groups such as the elderly and those with a history of mood disorders. Improved understanding can facilitate better recognition of symptoms and encourage affected individuals to seek medical advice and support.
Senate Resolution No. 110, introduced by Senator Beall, aims to designate the week of May 21, 2018, as Tardive Dyskinesia (TD) Awareness Week. The resolution seeks to promote understanding and awareness of TD, a debilitating movement disorder that can result from long-term use of dopamine receptor blocking agents (DRBAs), commonly used in the treatment of serious mental illnesses and gastrointestinal disorders. With over 60,000 Californians estimated to suffer from TD, this recognition is critical for improving public knowledge and encouraging regular screenings for affected individuals.
The sentiment behind SR 110 is predominantly positive, as it seeks to empower individuals affected by TD through education and awareness. Legislators and advocates view this resolution as a vital step towards addressing under-recognized health issues, thereby contributing to the improvement of mental health care and the well-being of those at risk. Supporters of the resolution believe that increasing awareness can lead to earlier detection and management of TD, reducing stigma and helping patients feel less isolated.
While the resolution is largely supported, there may be discussions around the healthcare system's accountability in screening and treating TD. Some might contend that awareness alone is insufficient without the implementation of systematic changes in patient care and treatment protocols. Critics may point out that while awareness is crucial, practical measures must also be taken to ensure those at risk have access to appropriate evaluations and ongoing support to manage their condition effectively.